Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Zoledronic Acid × 90 days × Clear all

Phase

Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Osteosarcoma 1 Neuroblastoma 1

Interventions

Specimen Handling 117 pembrolizumab 115 Cyclophosphamide 99 Magnetic Resonance Spectroscopy 94 Biopsy 88 fludarabine 75 Nivolumab 55 venetoclax 49 Carboplatin 36 Radiotherapy 35 Cetuximab 34 fludarabine phosphate 33 Paclitaxel 33 Gemcitabine 32 Cisplatin 32 Bevacizumab 32 Fluorouracil 30 atezolizumab 28 Azacitidine 28 Ipilimumab 25 Dexamethasone 25 Cytarabine 25 durvalumab 24 Temozolomide 24 Lenalidomide 24 Injections 24 Radiosurgery 23 Oxaliplatin 23 Leucovorin 22 Irinotecan 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05400603 2025-12-26

Aflac-NBL-2002

Emory University

Phase 1 Recruiting

Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡